Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects? [electronic resource]
Producer: 20151222Description: 188-90 p. digitalISSN:- 1471-1753
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.